MENLO PARK, Calif.--(BUSINESS WIRE)--CohBar, Inc. (TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics to treat diseases associated with aging, today provided a corporate update and reported financial results for the full year ending December 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
